EP Patent

EP3980005A4 — CARBACHOL-BRIMONIDINE FORMULATION FOR IMPROVING ANTI-PRESBYOPIA EFFECTS

Assigned to Visus Therapeutics Inc · Expires 2023-09-20 · 3y expired

What this patent protects

Patent listed against phentolamine-mesylate.

Drugs covered by this patent

phentolamine-mesylate (PHENTOLAMINE MESYLATE)

Patent Metadata

Patent number: EP3980005A4
Jurisdiction: EP
Classification: —
Expires: 2023-09-20
Drug substance claim: No
Drug product claim: No
Assignee: Visus Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.